Meta-Analysis
Copyright ©The Author(s) 2021.
World J Gastroenterol. Apr 14, 2021; 27(14): 1507-1523
Published online Apr 14, 2021. doi: 10.3748/wjg.v27.i14.1507
Table 4 Sensitivity analysis of outcomes (only randomized control trials included)
Period
Outcome
Studies
participants
Effect size OR, 95%CI (fixed/random)
Heterogeneity
Test for overall effect (fixed/random)
Publication bias
Study quality1
Favors
1995-2010Overall biliarycomplications56391.15 [0.28, 4.72]I2 = 92.2% (bP = 0.001)Z = 0.19/(P = 0.85)Egger: Bias = 2.63; P = 0.713 × 4, 2 × 1None
Bile leak56390.56 [0.28, 1.13]I2 = 0.0% (P = 0.72)Z = 1.62/(P = 0.11)Egger: Bias = 1.72; P = 0.083 × 4, 2 × 1None
Biliary stricture56390.45 [0.24, 0.85]I2 = 0.0% (P = 0.46)Z = 2.47/(aP = 0.014)Egger: Bias= -2.78; P = 0.103 × 4, 2 × 1With T-tube
Cholangitis45411.83 [0.36, 9.41]I2 = 65.6% (aP = 0.03)Z = 0.72/(P = 0.47)Egger: Bias = 3.39; P = 0.0543 × 4None
2010-2020Bile leak32771.38 [0.34, 5.65]I2 = 50.9% (P = 0.13)Z = 0.45/(P = 0.66)Egger: Bias = -1.94; P = 0.623 × 2, 2 × 1None
Biliary stricture32770.63 [0.06, 6.99]I2 = 80.3% (aP = 0.01)Z = 0.38/(P = 0.71)Egger: Bias = 1.08; P = 0.923 × 2, 2 × 1None